This work is licensed under the Creative Commons Attribution 4.0 International License.
Sherwin A, Wall T, Buggy DJ. Anesthesia and cancer recurrence. UpToDate. [Internet]. Wolters Kluwer. [cited 2023 Sep 4). Available at: https://www.uptodate.com/contents/anesthesia-and-cancer-recurrenceSherwinAWallTBuggyDJAnesthesia and cancer recurrenceUpToDate[Internet]. Wolters Kluwer. [cited 2023 Sep 4). Available at: https://www.uptodate.com/contents/anesthesia-and-cancer-recurrenceSearch in Google Scholar
Sessler DI, Riedel B. Anesthesia and cancer recurrence: context for divergent study outcomes. Anesthesiology 2019; 130: 3–5. doi: 10.1097/ALN.0000000000002506SesslerDIRiedelBAnesthesia and cancer recurrence: context for divergent study outcomesAnesthesiology20191303510.1097/ALN.0000000000002506Open DOISearch in Google Scholar
Lyden D, Ghajar CM, Correia AL, Aguirre-Ghiso JA, Cai S, Rescigno M, et al. Metastasis. Cancer Cell 2022; 40: 787–91. doi: 10.1016/j.ccell.2022.07.010LydenDGhajarCMCorreiaALAguirre-GhisoJACaiSRescignoMMetastasisCancer Cell2022407879110.1016/j.ccell.2022.07.010Open DOISearch in Google Scholar
Margraf A, Ludwig N, Zarbock A, Rossaint J. Systemic inflammatory response syndrome after surgery: mechanisms and protection. Anesth Analg 2020; 131: 1693–707. doi: 10.1213/ANE.0000000000005175MargrafALudwigNZarbockARossaintJSystemic inflammatory response syndrome after surgery: mechanisms and protectionAnesth Analg2020131169370710.1213/ANE.0000000000005175Open DOISearch in Google Scholar
Dinarello CA. Historical insights into cytokines. Eur J Immunol 2007; 37(Suppl 1): S34–45. doi: 10.1002/eji.200737772DinarelloCAHistorical insights into cytokinesEur J Immunol200737Suppl 1S344510.1002/eji.200737772Open DOISearch in Google Scholar
Tavare AN, Perry NJ, Benzonana LL, Takata M, Ma D. Cancer recurrence after surgery: direct and indirect effects of anesthetic agents. Int J Cancer 2012; 130: 1237–50. doi: 10.1002/ijc.26448TavareANPerryNJBenzonanaLLTakataMMaDCancer recurrence after surgery: direct and indirect effects of anesthetic agentsInt J Cancer201213012375010.1002/ijc.26448Open DOISearch in Google Scholar
Egger G. [Acute inflammation: basics, pathophysiology and clinical manifestations of non-specific imunity]. [German]. Wien, New York: Springer Verlag; 2005.EggerG[Acute inflammation: basics, pathophysiology and clinical manifestations of non-specific imunity]. [German]Wien, New YorkSpringer Verlag2005Search in Google Scholar
Brøchner AC, Toft P. Pathophysiology of the systemic inflammatory response after major accidental trauma. Scand J Trauma Resusc Emerg Med 2009; 17: 43. doi: 10.1186/1757-7241-17-43BrøchnerACToftPPathophysiology of the systemic inflammatory response after major accidental traumaScand J Trauma Resusc Emerg Med2009174310.1186/1757-7241-17-43Open DOISearch in Google Scholar
Potočnik I, Novak-Janković V, Šostarič M, Jerin A, Štupnik T, Skitek M, et al. Antiinflammatory effect of sevoflurane in open lung surgery with one-lung ventilation. Croat Med J 2014; 55: 628–37. doi: 10.3325/cmj.2014.55.628PotočnikINovak-JankovićVŠostaričMJerinAŠtupnikTSkitekMAntiinflammatory effect of sevoflurane in open lung surgery with one-lung ventilationCroat Med J2014556283710.3325/cmj.2014.55.628Open DOISearch in Google Scholar
Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 2021; 47: 1181–247. doi: 10.1007/s00134-021-06506-yEvansLRhodesAAlhazzaniWAntonelliMCoopersmithCMFrenchCSurviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021Intensive Care Med202147118124710.1007/s00134-021-06506-yOpen DOISearch in Google Scholar
Vincent JL. Update on surgical sepsis syndrome. Br J Surg 2017; 104: e34–40, doi: 10.1002/bjs.10451VincentJLUpdate on surgical sepsis syndromeBr J Surg2017104e344010.1002/bjs.10451Open DOISearch in Google Scholar
Stevenson GW, Hall SC, Rudnick S, Seleny FL, Stevenson HC. The effect of anesthetic agents on the human immune response. Anesthesiology 1990; 72: 542–52. doi: 10.1097/00000542-199003000-00024StevensonGWHallSCRudnickSSelenyFLStevensonHCThe effect of anesthetic agents on the human immune responseAnesthesiology199025425210.1097/00000542-199003000-00024Open DOISearch in Google Scholar
Colucci DG, Puig NR, Hernandez-Pand R. Influence of anaesthetic drugs on immune response: from inflammation to immunosuppression. OA Anaesthetics 2013; 30: 21. doi: 10.13172/2052-7853-1-3-1091ColucciDGPuigNRHernandez-PandRInfluence of anaesthetic drugs on immune response: from inflammation to immunosuppressionOA Anaesthetics2013302110.13172/2052-7853-1-3-1091Open DOISearch in Google Scholar
Crozier TA, Müller JE, Quittkat D, Sydow M, Wuttke W, Kettler D. Effect of anaesthesia on the cytokine responses to abdominal surgery. Br J Anaesth 1994; 72: 280–5. doi: 10.1093/bja/72.3.280CrozierTAMüllerJEQuittkatDSydowMWuttkeWKettlerDEffect of anaesthesia on the cytokine responses to abdominal surgeryBr J Anaesth199472280510.1093/bja/72.3.280Open DOISearch in Google Scholar
Zhang Y, Lin JX, Vilcek J. Synthesis of interleukin 6 (interferon-beta 2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. J Biol Chem 1988; 263: 6177–82. PMID: 2452159ZhangYLinJXVilcekJSynthesis of interleukin 6 (interferon-beta 2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMPJ Biol Chem19882636177822452159Search in Google Scholar
Lopker A, Abood LG, Hoss W, Lionetti FJ. Stereoselective muscarinic acetylcholine and opiate receptors in human phagocytic leukocytes. Biochem Pharmacol 1980; 29: 1361–5. doi: 10.1016/0006-2952(80)90431-1LopkerAAboodLGHossWLionettiFJStereoselective muscarinic acetylcholine and opiate receptors in human phagocytic leukocytesBiochem Pharmacol1980291361510.1016/0006-2952(80)90431-1Open DOISearch in Google Scholar
Rossano F, Tufano R, Cipollaro de L’Ero G, Servillo G, Baroni A, Tufano MA. Anesthetic agents induce human mononuclear leucocytes to release cytokines. Immunopharmacol Immunotoxicol 1992; 14: 439–50. doi: 10.3109/08923979209005403RossanoFTufanoRCipollaro de L’EroGServilloGBaroniATufanoMAAnesthetic agents induce human mononuclear leucocytes to release cytokinesImmunopharmacol Immunotoxicol1992144395010.3109/08923979209005403Open DOISearch in Google Scholar
Malafoglia V, Ilari S, Vitiello L, Tenti M, Balzani E, Muscoli C, et al. The interplay between chronic pain, opioids, and the immune system. Neuroscientist 2022; 28: 613–27. doi: 10.1177/10738584211030493MalafogliaVIlariSVitielloLTentiMBalzaniEMuscoliCThe interplay between chronic pain, opioids, and the immune systemNeuroscientist2022286132710.1177/10738584211030493Open DOISearch in Google Scholar
Dubowitz JA, Cata JP, De Silva AP, Braat S, Shan D, Yee K, et al. Global Onco-Anaesthesia Research Collaboration Group. Volatile anaesthesia and peri-operative outcomes related to cancer: a feasibility and pilot study for a large, randomised control trial. Anaesthesia 2021; 76: 1198–206. doi: 10.1111/anae.15354DubowitzJACataJPDe SilvaAPBraatSShanDYeeKGlobal Onco-Anaesthesia Research Collaboration Group. Volatile anaesthesia and peri-operative outcomes related to cancer: a feasibility and pilot study for a large, randomised control trialAnaesthesia202176119820610.1111/anae.15354Open DOISearch in Google Scholar
Galoș EV, Tat TF, Popa R, Efrimescu CI, Finnerty D, Buggy DJ, et al. Neutrophil extracellular trapping and angiogenesis biomarkers after intravenous or inhalation anaesthesia with or without intravenous lidocaine for breast cancer surgery: a prospective, randomised trial. Br J Anaesth 2020; 125: 712–21. doi: 10.1016/j.bja.2020.05.003GaloșEVTatTFPopaREfrimescuCIFinnertyDBuggyDJNeutrophil extracellular trapping and angiogenesis biomarkers after intravenous or inhalation anaesthesia with or without intravenous lidocaine for breast cancer surgery: a prospective, randomised trialBr J Anaesth20201257122110.1016/j.bja.2020.05.003Open DOISearch in Google Scholar
Kurosawa S, Kato M. Anesthetics, immune cells, and immune responses. J Anesth 2008; 22: 263–77. doi: 10.1007/s00540-008-0626-2KurosawaSKatoMAnesthetics, immune cells, and immune responsesJ Anesth2008222637710.1007/s00540-008-0626-2Open DOISearch in Google Scholar
Salo M. Effects of lignocaine and bupivacaine on immunoglobulin synthesis in vitro. Eur J Anaesth 1990; 7: 133–40.SaloMEffects of lignocaine and bupivacaine on immunoglobulin synthesis in vitroEur J Anaesth1990713340Search in Google Scholar
Novak-Jankovič V, Paver-Eržen V, Bovill JG, Ihan A, Osredkar J. Effect of epidural and intravenous clonidine on the neuro-endocrine and immune stress response in patients undergoing lung surgery. Eur J Anaesthesiol 2000;17: 50–6. doi:10.1046/j.1365-2346.2000.00602.xNovak-JankovičVPaver-ErženVBovillJGIhanAOsredkarJEffect of epidural and intravenous clonidine on the neuro-endocrine and immune stress response in patients undergoing lung surgeryEur J Anaesthesiol20001750610.1046/j.1365-2346.2000.00602.xOpen DOISearch in Google Scholar
Novak-Jankovič V, Paver-Eržen V, Požlep G. How can we reduce stress response in patients undergoing lung surgery? Acta Med Croatica 1997; 51: 89.Novak-JankovičVPaver-ErženVPožlepGHow can we reduce stress response in patients undergoing lung surgery?Acta Med Croatica19975189Search in Google Scholar
Cata JP, Wang H, Gottumukkala V, Reuben J, Sessler DI. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth 2013; 110: 690–701. doi: 10.1093/bja/aet068CataJPWangHGottumukkalaVReubenJSesslerDIInflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusionsBr J Anaesth201311069070110.1093/bja/aet068Open DOISearch in Google Scholar
Dantzer R. Neuroimmune interactions: from the brain to the immune system and vice versa. Physiol Rev 2018; 98: 1477–504. doi: 10.1152/physrev.00039.2016DantzerRNeuroimmune interactions: from the brain to the immune system and vice versaPhysiol Rev201898147750410.1152/physrev.00039.2016Open DOISearch in Google Scholar
Smith SM, Vale WW. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci 2006; 8: 383–95. doi: 10.31887/DCNS.2006.8.4/ssmithSmithSMValeWWThe role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stressDialogues Clin Neurosci200683839510.31887/DCNS.2006.8.4/ssmithOpen DOISearch in Google Scholar
Velkeniers B., Dogusan Z., Naessens F. et al. Prolactin, growth hormone and the immune system in humans. Cell Mol Life Sci 1998; 54: 1102–8. doi: 10.1007/s000180050239VelkeniersB.DogusanZ.NaessensF.Prolactin, growth hormone and the immune system in humansCell Mol Life Sci1998541102810.1007/s000180050239Open DOISearch in Google Scholar
Dhabhar FS. Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection versus immunopathology. 2008; Allergy Asthma Clin Immunol 2008; 4: 2–11. doi:10.1186/1710-1492-4-1-2DhabharFSEnhancing versus suppressive effects of stress on immune function: implications for immunoprotection versus immunopathology. 2008Allergy Asthma Clin Immunol2008421110.1186/1710-1492-4-1-2Open DOISearch in Google Scholar
Sessler DI, Pei L, Huang Y, Fleischmann E, Marhofer P, Kurz A, et al; Breast Cancer Recurrence Collaboration. Recurrence of breast cancer after regional or general anaesthesia: a randomised controlled trial. Lancet 2019; 394: 1807–15. doi: 10.1016/S0140-6736(19)32313-XSesslerDIPeiLHuangYFleischmannEMarhoferPKurzABreast Cancer Recurrence CollaborationRecurrence of breast cancer after regional or general anaesthesia: a randomised controlled trialLancet201939418071510.1016/S0140-6736(19)32313-XOpen DOISearch in Google Scholar
Du YT, Li YW, Zhao BJ, Guo XY, Feng Y, Zuo MZ, Fu C, et al; Peking University Clinical Research Program Study Group. Long-term survival after combined epidural-general anesthesia or general anesthesia alone: follow-up of a randomized trial. Anesthesiology 2021; 135: 233–45. doi: 10.1097/ALN.0000000000003835DuYTLiYWZhaoBJGuoXYFengYZuoMZFuCPeking University Clinical Research Program Study GroupLong-term survival after combined epidural-general anesthesia or general anesthesia alone: follow-up of a randomized trialAnesthesiology20211352334510.1097/ALN.0000000000003835Open DOISearch in Google Scholar
Xu ZZ, Li HJ, Li MH, Huang SM, Li X, Liu QH, et al. Epidural anesthesia-analgesia and recurrence-free survival after lung cancer surgery: a randomized trial. Anesthesiology 2021; 135: 419–32. doi: 10.1097/ALN.0000000000003873XuZZLiHJLiMHHuangSMLiXLiuQHEpidural anesthesia-analgesia and recurrence-free survival after lung cancer surgery: a randomized trialAnesthesiology20211354193210.1097/ALN.0000000000003873Open DOISearch in Google Scholar
Vahabi S, Eatemadi A. Effects of anesthetic and analgesic techniques on cancer metastasis. Biomed Pharmacother 2017; 87: 1–7. doi: 10.1016/j.biopha.2016.12.073VahabiSEatemadiAEffects of anesthetic and analgesic techniques on cancer metastasisBiomed Pharmacother2017871710.1016/j.biopha.2016.12.073Open DOISearch in Google Scholar
Potočnik I, Hostnik A, Markovič-Božič J. Do inhalational anesthetic agents still hold their place in modern anesthesia practice? Signa Vitae 2019; 15: 14–17. doi: 10.22514/SV152.092019.1PotočnikIHostnikAMarkovič-BožičJDo inhalational anesthetic agents still hold their place in modern anesthesia practice?Signa Vitae201915141710.22514/SV152.092019.1Open DOISearch in Google Scholar
Markovic-Bozic J, Karpe B, Potocnik I, Jerin A, Vranic A, Novak-Jankovic V. Effect of propofol and sevoflurane on the inflammatory response of patients undergoing craniotomy. BMC Anesthesiol 2016; 16: 18. doi: 10.1186/s12871-016-0182-5Markovic-BozicJKarpeBPotocnikIJerinAVranicANovak-JankovicVEffect of propofol and sevoflurane on the inflammatory response of patients undergoing craniotomyBMC Anesthesiol2016161810.1186/s12871-016-0182-5Open DOISearch in Google Scholar
Jiao B, Yang C, Huang NN, Yang N, Jia Wei J, Xu H. Relationship between volatile anesthetics and tumor progression: unveiling the mystery. Curr Med Sci 2018; 38: 962–7. doi: 10.1007/s11596-018-1970-6JiaoBYangCHuangNNYangNJia WeiJXuHRelationship between volatile anesthetics and tumor progression: unveiling the mysteryCurr Med Sci201838962710.1007/s11596-018-1970-6Open DOISearch in Google Scholar
Zhang L, Zhang J, Yang L, Dong Y, Zhang Y, Xie Z. Isoflurane and sevoflurane increase interleukin-6 levels through the nuclear factor-kappa B pathway in neuroglioma cells. Br J Anaesth 2013; 110(Suppl 1): i82–91. doi: 10.1093/bja/aet115ZhangLZhangJYangLDongYZhangYXieZIsoflurane and sevoflurane increase interleukin-6 levels through the nuclear factor-kappa B pathway in neuroglioma cellsBr J Anaesth2013110Suppl 1i829110.1093/bja/aet115Open DOISearch in Google Scholar
Ulbrich F, Eisert L, Buerkle H, Goebel U, Schallner N. Propofol, but not keta-mine or midazolam, exerts neuroprotection after ischemic injury by inhibition of Toll-like receptor 4 and nuclear factor kappa-light-chain-enhancer of activated B-cell signalling. A combined in vitro study and animal study. Eur J Anaesthesiol 2016; 33: 670–80. doi: 10.1097/EJA.0000000000000449UlbrichFEisertLBuerkleHGoebelUSchallnerNPropofol, but not keta-mine or midazolam, exerts neuroprotection after ischemic injury by inhibition of Toll-like receptor 4 and nuclear factor kappa-light-chain-enhancer of activated B-cell signalling. A combined in vitro study and animal studyEur J Anaesthesiol2016336708010.1097/EJA.0000000000000449Open DOISearch in Google Scholar
Sun C, Liu P, Pei L, Zhao M, Huang Y. Propofol inhibits proliferation and augments the anti-tumor effect of doxorubicin and paclitaxel partly through promoting ferroptosis in triple-negative breast cancer cells. Front Oncol 2022; 12: 837974. doi: 10.3389/fonc.2022.837974SunCLiuPPeiLZhaoMHuangYPropofol inhibits proliferation and augments the anti-tumor effect of doxorubicin and paclitaxel partly through promoting ferroptosis in triple-negative breast cancer cellsFront Oncol20221283797410.3389/fonc.2022.837974Open DOISearch in Google Scholar
El Azab SR, Rosseel PM, De Lange JJ, van Wijk EM, van Strik R, Scheffer GJ. Effect of VIMA with sevoflurane versus TIVA with propofol or midazolam-sufentanil on the cytokine response during CABG surgery. Eur J Anaesthesiol 2002; 19: 276–82. doi: 10.1017/s0265021502000443El AzabSRRosseelPMDe LangeJJvan WijkEMvan StrikRSchefferGJEffect of VIMA with sevoflurane versus TIVA with propofol or midazolam-sufentanil on the cytokine response during CABG surgeryEur J Anaesthesiol2002192768210.1017/s0265021502000443Open DOISearch in Google Scholar
Minou AF, Dzyadzko AM, Shcherba AE, Rummo OO. The influence of pharmacological preconditioning with sevoflurane on incidence of early allograft dysfunction in liver transplant recipients. Anesthesiol Res Pract 2012; 2012: 930487. doi: 10.1155/2012/930487MinouAFDzyadzkoAMShcherbaAERummoOOThe influence of pharmacological preconditioning with sevoflurane on incidence of early allograft dysfunction in liver transplant recipientsAnesthesiol Res Pract2012201293048710.1155/2012/930487Open DOISearch in Google Scholar
Jerin A, Pozar-Lukanovic N, Sojar V, Stanisavljevic D, Paver-Erzen V, Osredkar J. Balance of pro- and anti-inflammatory cytokines in liver surgery. Clin Chem Lab Med 2003; 41: 899–903. doi: 10.1515/CCLM.2003.136JerinAPozar-LukanovicNSojarVStanisavljevicDPaver-ErzenVOsredkarJBalance of pro- and anti-inflammatory cytokines in liver surgeryClin Chem Lab Med20034189990310.1515/CCLM.2003.136Open DOISearch in Google Scholar
Jabaudon M, Zhai R, Blondonnet R, Bonda WLM. Inhaled sedation in the intensive care unit. Anaesth Crit Care Pain Med 2022; 41: 101133. doi: 10.1016/j.accpm.2022.101133JabaudonMZhaiRBlondonnetRBondaWLMInhaled sedation in the intensive care unitAnaesth Crit Care Pain Med20224110113310.1016/j.accpm.2022.101133Open DOISearch in Google Scholar
Song Z, Tan J. Effects of anesthesia and anesthetic techniques on metastasis of lung cancers: a narrative review. Cancer Manag Res 2022; 14: 189–204. doi: 10.2147/CMAR.S343772SongZTanJEffects of anesthesia and anesthetic techniques on metastasis of lung cancers: a narrative reviewCancer Manag Res20221418920410.2147/CMAR.S343772Open DOISearch in Google Scholar
Oh CS, Park HJ, Piao L, Sohn KM, Koh SE, Hwang DY, et al. Expression profiles of immune cells after propofol or sevoflurane anesthesia for colorectal cancer surgery: a prospective double-blind randomized trial. Anesthesiology 2022; 136: 448–58. doi: 10.1097/ALN.0000000000004119OhCSParkHJPiaoLSohnKMKohSEHwangDYExpression profiles of immune cells after propofol or sevoflurane anesthesia for colorectal cancer surgery: a prospective double-blind randomized trialAnesthesiology20221364485810.1097/ALN.0000000000004119Open DOISearch in Google Scholar
Quan Y, Li S, Wang Y, Liu G, Lv Z, Wang Z. Propofol and sevoflurane alleviate malignant biological behavior and cisplatin resistance of Xuanwei lung adenocarcinoma by modulating the Wnt/β-catenin pathway and PI3K/AKT athway. Anticancer Agents Med Chem 2022; 22: 2098–2108. doi: 10.2174/1871520621666211026092405QuanYLiSWangYLiuGLvZWangZPropofol and sevoflurane alleviate malignant biological behavior and cisplatin resistance of Xuanwei lung adenocarcinoma by modulating the Wnt/β-catenin pathway and PI3K/AKT athwayAnticancer Agents Med Chem2022222098210810.2174/1871520621666211026092405Open DOISearch in Google Scholar
Yap A, Lopez-Olivo MA, Dubowitz J, Hiller J, Riedel B; Global Onco-Anesthesia Research Collaboration Group. Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia. Can J Anaesth 2019; 66: 546–61. doi: 10.1007/s12630-019-01330-xYapALopez-OlivoMADubowitzJHillerJRiedelBGlobal Onco-Anesthesia Research Collaboration GroupAnesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesiaCan J Anaesth2019665466110.1007/s12630-019-01330-xOpen DOISearch in Google Scholar
Hovaguimian F, Braun J, Z’graggen BR, Schläpfer M, Dumrese C, Ewald C, et al. Anesthesia and circulating tumor cells in primary breast cancer patients: a randomized controlled trial. Anesthesiology 2020; 133: 548–58. doi: 10.1097/ALN.0000000000003409HovaguimianFBraunJZ’graggenBRSchläpferMDumreseCEwaldCAnesthesia and circulating tumor cells in primary breast cancer patients: a randomized controlled trialAnesthesiology20201335485810.1097/ALN.0000000000003409Open DOISearch in Google Scholar
Buggy DJ, Riedel B, Sessler DI. Can anaesthetic technique influence cancer outcome? The next steps…. Br J Anaesth 2021; 127: 5–7. doi: 10.1016/j.bja.2021.04.005BuggyDJRiedelBSesslerDICan anaesthetic technique influence cancer outcome? The next steps…Br J Anaesth20211275710.1016/j.bja.2021.04.005Open DOISearch in Google Scholar
Maalouf M, Reddy AJ, Mazboudi P, Min M, Rawal R, Curow CA, et al. An analysis of lidocaine usage in the treatment of squamous cell carcinoma. Cureus 2023; 15: e35614. doi: 10.7759/cureus.35614MaaloufMReddyAJMazboudiPMinMRawalRCurowCAAn analysis of lidocaine usage in the treatment of squamous cell carcinomaCureus202315e3561410.7759/cureus.35614Open DOISearch in Google Scholar
Xing W, Chen DT, Pan JH, Chen YH, Yan Y, Li Q, et al. Lidocaine induces apoptosis and suppresses tumor growth in human hepatocellular carcinoma cells in vitro and in a xenograft model in vivo. Anesthesiology 2017; 126: 868–81. doi: 10.1097/ALN.0000000000001528XingWChenDTPanJHChenYHYanYLiQLidocaine induces apoptosis and suppresses tumor growth in human hepatocellular carcinoma cells in vitro and in a xenograft model in vivoAnesthesiology20171268688110.1097/ALN.0000000000001528Open DOISearch in Google Scholar
Zhao L, Ma N, Liu G, Mao N, Chen F, Li J. Lidocaine inhibits hepatocellular carcinoma development by modulating circ_ITCH/miR-421/CPEB3 axis. Dig Dis Sci 2021; 66: 4384–97. doi: 10.1007/s10620-020-06787-1ZhaoLMaNLiuGMaoNChenFLiJLidocaine inhibits hepatocellular carcinoma development by modulating circ_ITCH/miR-421/CPEB3 axisDig Dis Sci20216643849710.1007/s10620-020-06787-1Open DOISearch in Google Scholar
Zhang H, Yang L, Zhu X, Zhu M, Sun Z, Cata JP, et al. Association between intraoperative intravenous lidocaine infusion and survival in patients undergoing pancreatectomy for pancreatic cancer: a retrospective study. Br J Anaesth 2020; 125: 141–8. doi: 10.1016/j.bja.2020.03.034ZhangHYangLZhuXZhuMSunZCataJPAssociation between intraoperative intravenous lidocaine infusion and survival in patients undergoing pancreatectomy for pancreatic cancer: a retrospective studyBr J Anaesth2020125141810.1016/j.bja.2020.03.034Open DOISearch in Google Scholar
Diaz-Cambronero O, Mazzinari G, Cata JP. Perioperative opioids and colorectal cancer recurrence: a systematic review of the literature. Pain Manag 2018; 8: 353–61. doi: 10.2217/pmt-2018-0029Diaz-CambroneroOMazzinariGCataJPPerioperative opioids and colorectal cancer recurrence: a systematic review of the literaturePain Manag201883536110.2217/pmt-2018-0029Open DOISearch in Google Scholar
Boudreau DM, Chen L, Yu O, Bowles EJA, Chubak J. Risk of second breast cancer events with chronic opioid use in breast cancer survivors. Pharmacoepidemiol Drug Saf 2019; 28: 740–53. doi: 10.1002/pds.4779BoudreauDMChenLYuOBowlesEJAChubakJRisk of second breast cancer events with chronic opioid use in breast cancer survivorsPharmacoepidemiol Drug Saf2019287405310.1002/pds.4779Open DOISearch in Google Scholar
Shavit Y, Ben-Eliyahu S, Zeidel A, Beilin B. Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose timing study. Neuroimmunomodulation 2004; 11: 255–60. doi: 10.1159/000078444ShavitYBen-EliyahuSZeidelABeilinBEffects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose timing studyNeuroimmunomodulation2004112556010.1159/000078444Open DOISearch in Google Scholar
Saeed I, La Caze A, Hollmann MW, Shaw PN, Parat MO. New insights on tramadol and immunomodulation. Curr Oncol Rep 2021; 23: 123. doi: 10.1007/s11912-021-01121-ySaeedILa CazeAHollmannMWShawPNParatMONew insights on tramadol and immunomodulationCurr Oncol Rep20212312310.1007/s11912-021-01121-yOpen DOISearch in Google Scholar
Cata JP, Singh V, Lee BM, Villarreal J, Mehran JR, Yu J, et al. Intraoperative use of dexmedetomidine is associated with decreased overall survival after lung cancer surgery. J Anaesthesiol Clin Pharmacol 2017; 33: 317–23. doi: 10.4103/joacp.JOACP_299_16CataJPSinghVLeeBMVillarrealJMehranJRYuJIntraoperative use of dexmedetomidine is associated with decreased overall survival after lung cancer surgeryJ Anaesthesiol Clin Pharmacol2017333172310.4103/joacp.JOACP_299_16Open DOISearch in Google Scholar
Lavon H, Matzner P, Benbenishty A, Sorski L, Rossene E, Haldar R, et al. Dexmedetomidine promotes metastasis in rodent models of breast, lung, and colon cancers. Br J Anaesth 2018; 120: 188–96. doi: 10.1016/j.bja.2017.11.004LavonHMatznerPBenbenishtyASorskiLRosseneEHaldarRDexmedetomidine promotes metastasis in rodent models of breast, lung, and colon cancersBr J Anaesth20181201889610.1016/j.bja.2017.11.004Open DOISearch in Google Scholar
Forget P, Berlière M, Poncelet A, De Kock M. Effect of clonidine on oncological outcomes after breast and lung cancer surgery. Br J Anaesth 2018; 121: 103–4. doi: 10.1016/j.bja.2018.04.020ForgetPBerlièreMPonceletADe KockMEffect of clonidine on oncological outcomes after breast and lung cancer surgeryBr J Anaesth2018121103410.1016/j.bja.2018.04.020Open DOISearch in Google Scholar
Zhang Y, Li M, Cui E, Zhang H, Zhu X, Zhou J, et al. Dexmedetomidine attenuates sevoflurane induced neurocognitive impairment through α2 adrenoceptors. Mol Med Rep 2021; 23: 38. doi: 10.3892/mmr.2020.11676ZhangYLiMCuiEZhangHZhuXZhouJDexmedetomidine attenuates sevoflurane induced neurocognitive impairment through α2 adrenoceptorsMol Med Rep2021233810.3892/mmr.2020.11676Open DOISearch in Google Scholar
Zappavigna S, Cossu AM, Grimaldi A, Bocchetti M, Ferraro GA, Nicoletti GF, et al. Anti-inflammatory drugs as anticancer agents. Int J Mol Sci 2020; 21: 2605. doi: 10.3390/ijms21072605ZappavignaSCossuAMGrimaldiABocchettiMFerraroGANicolettiGFAnti-inflammatory drugs as anticancer agentsInt J Mol Sci202021260510.3390/ijms21072605Open DOISearch in Google Scholar
Musselman RP, Bennett S, Li W, Mamdani M, Gomes T, van Walraven C, et al. Association between perioperative beta blocker use and cancer survival following surgical resection. Eur J Surg Oncol 2018; 44: 1164–69. doi: 10.1016/j.ejso.2018.05.012MusselmanRPBennettSLiWMamdaniMGomesTvan WalravenCAssociation between perioperative beta blocker use and cancer survival following surgical resectionEur J Surg Oncol20184411646910.1016/j.ejso.2018.05.012Open DOISearch in Google Scholar
Kalfeist L, Galland L, Ledys F, Ghiringhelli F, Limagne E, Ladoire S. Impact of glucocorticoid use in oncology in the immunotherapy era. Cells 2022; 11: 770. doi: 10.3390/cells11050770KalfeistLGallandLLedysFGhiringhelliFLimagneELadoireSImpact of glucocorticoid use in oncology in the immunotherapy eraCells20221177010.3390/cells11050770Open DOISearch in Google Scholar
Ristescu AI, Tiron CE, Tiron A, Grigoras I. Exploring hyperoxia effects in cancer-from perioperative clinical data to potential molecular mechanisms. Biomedicines 2021; 9: 1213. doi: 10.3390/biomedicines9091213RistescuAITironCETironAGrigorasIExploring hyperoxia effects in cancer-from perioperative clinical data to potential molecular mechanismsBiomedicines20219121310.3390/biomedicines9091213Open DOISearch in Google Scholar